Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal

Fingolimod (FTY) is a disease modifying therapy for relapsing remitting multiple sclerosis (RRMS) which can lead to severe lymphopenia requiring therapy discontinuation in order to avoid adverse events. However, this can result in severe disease reactivation occasionally presenting with tumefactive...

Descripción completa

Detalles Bibliográficos
Autores principales: Koska, Valeria, Förster, Moritz, Brouzou, Katja, Arat, Ercan, Albrecht, Philipp, Aktas, Orhan, Küry, Patrick, Meuth, Sven G., Kremer, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585856/
https://www.ncbi.nlm.nih.gov/pubmed/34777236
http://dx.doi.org/10.3389/fneur.2021.785180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585856/
https://www.ncbi.nlm.nih.gov/pubmed/34777236
http://dx.doi.org/10.3389/fneur.2021.785180

Ejemplares similares